Vaccinex, Inc. (VCNX)

Vaccinex Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-20.25	-19.82	-22.38	-28.85	-31.86
Depreciation & Amortization	0.12	0.21	0.17	0.31	0.25
Share-Based Compensation	0.47	0.55	0.54	0.73	0.45
Other Operating Activities	2.42	-0.01	-3.63	-0.84	0.45
Operating Cash Flow	-17.23	-19.07	-25.3	-28.65	-30.72
Capital Expenditures	-0.07	-0.1	-0.03	-0.29	-0.08
Change in Investments	0	0	0	0	14.15
Investing Cash Flow	-0.07	-0.1	-0.03	-0.29	14.07
Share Issuance / Repurchase	12.52	17.05	31.86	27.78	13.8
Debt Issued / Paid	-0.07	-0.08	-8.54	8.98	0
Financing Cash Flow	12.45	16.98	23.32	36.76	13.8
Net Cash Flow	-4.86	-2.2	-2.01	7.82	-2.84
Free Cash Flow	-17.3	-19.17	-25.33	-28.94	-30.79
Free Cash Flow Margin	-3035.26%	-6972.00%	-2814.44%	-4629.92%	-5887.76%
Free Cash Flow Per Share	-37.31	-94.88	-184.38	-323.46	-502.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).